» Articles » PMID: 11238939

A C-terminal Region of RAG1 Contacts the Coding DNA During V(D)J Recombination

Overview
Journal Mol Cell Biol
Specialty Cell Biology
Date 2001 Mar 10
PMID 11238939
Citations 20
Authors
Affiliations
Soon will be listed here.
Abstract

The site-specific DNA rearrangement process, called V(D)J recombination, creates much of the diversity of immune receptor molecules in the adaptive immune system. Central to this reaction is the organization of the protein-DNA complex containing the proteins RAG1 and RAG2 and their DNA targets. A long-term goal is to appreciate the three-dimensional relationships between the proteins and DNA that allow the assembly of the appropriate reaction intermediates, resulting in concerted cleavage and directed rejoining of the DNA ends. Previous cross-linking approaches have mapped RAG1 contacts on the DNA. RAG1 protein contacts the DNA at the conserved heptamer and nonamer sequences as well as at the coding DNA adjacent to the heptamer. Here we subject RAG1, covalently cross-linked to DNA substrates, to partial cyanogen bromide degradation or trypsin proteolysis in order to map contacts on the protein. We find that coding-sequence contacts occur near the C terminus of RAG1, while contacts made within the recombination signal sequence occur nearer the N terminus of the core region of RAG1. A deletion protein lacking the C-terminal DNA-contacting region is still capable of making the N-terminal contacts. This suggests that the two binding interactions may exist on two separate domains of the protein. A trypsin cleavage pattern of the native protein supports this conclusion. A two-domain model for RAG1 is evaluated with respect to the larger recombination complex.

Citing Articles

The recombinase activating genes: architects of immune diversity during lymphocyte development.

Braams M, Pike-Overzet K, Staal F Front Immunol. 2023; 14:1210818.

PMID: 37497222 PMC: 10367010. DOI: 10.3389/fimmu.2023.1210818.


RAG Deficiency: Two Genes, Many Diseases.

Delmonte O, Schuetz C, Notarangelo L J Clin Immunol. 2018; 38(6):646-655.

PMID: 30046960 PMC: 6643099. DOI: 10.1007/s10875-018-0537-4.


Hypomorphic mutations alter the preimmune repertoire at early stages of lymphoid development.

Ott de Bruin L, Bosticardo M, Barbieri A, Lin S, Rowe J, Poliani P Blood. 2018; 132(3):281-292.

PMID: 29743177 PMC: 6053949. DOI: 10.1182/blood-2017-12-820985.


Characterization of T and B cell repertoire diversity in patients with RAG deficiency.

Lee Y, Frugoni F, Dobbs K, Tirosh I, Du L, Ververs F Sci Immunol. 2017; 1(6).

PMID: 28783691 PMC: 5586490. DOI: 10.1126/sciimmunol.aah6109.


Human RAG mutations: biochemistry and clinical implications.

Notarangelo L, Kim M, Walter J, Lee Y Nat Rev Immunol. 2016; 16(4):234-46.

PMID: 26996199 PMC: 5757527. DOI: 10.1038/nri.2016.28.


References
1.
Sadofsky M, Hesse J, McBlane J, Gellert M . Expression and V(D)J recombination activity of mutated RAG-1 proteins. Nucleic Acids Res. 1993; 21(24):5644-50. PMC: 310529. DOI: 10.1093/nar/21.24.5644. View

2.
McMahan S, Burgess R . Mapping protease susceptibility sites on the Escherichia coli transcription factor sigma70. Biochemistry. 1999; 38(38):12424-31. DOI: 10.1021/bi990824x. View

3.
Van Gent D, McBlane J, Ramsden D, Sadofsky M, Hesse J, Gellert M . Initiation of V(D)J recombination in a cell-free system. Cell. 1995; 81(6):925-34. DOI: 10.1016/0092-8674(95)90012-8. View

4.
Sadofsky M, Hesse J, Van Gent D, Gellert M . RAG-1 mutations that affect the target specificity of V(D)j recombination: a possible direct role of RAG-1 in site recognition. Genes Dev. 1995; 9(17):2193-9. DOI: 10.1101/gad.9.17.2193. View

5.
McBlane J, Van Gent D, Ramsden D, Romeo C, Cuomo C, Gellert M . Cleavage at a V(D)J recombination signal requires only RAG1 and RAG2 proteins and occurs in two steps. Cell. 1995; 83(3):387-95. DOI: 10.1016/0092-8674(95)90116-7. View